PITAVASTATIN News
PITAVASTATIN currently has 0 news articles, with 12 predicted indications.
This page combines the AI-predicted indications for PITAVASTATIN with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Evidence level: L5
- Predicted indications (12):
- hyperlipidemia, familial combined, LPL related (99.0%)
- obsolete familial combined hyperlipidemia (99.0%)
- homozygous familial hypercholesterolemia (100.0%)
- hyperlipoproteinemia (100.0%)
- familial hypercholesterolemia (100.0%)
- cholesterol-ester transfer protein deficiency (100.0%)
- hypercholesterolemia, autosomal dominant (100.0%)
- hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency (100.0%)
- HIV infectious disease (100.0%)
- neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter (100.0%)
- hyperlipidemia due to hepatic triglyceride lipase deficiency (99.9%)
- simian immunodeficiency virus infection (99.9%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.